Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2030 to 2079 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2030\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanine aminotransferase 2; glutamic-pyruvate transaminase 2. [source:refseq;acc:nm\_133443]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
189.999\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.677\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00883\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2031\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
traf and tnf receptor-associated protein; ets1-associated protein 2. [source:refseq;acc:nm\_016614]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.466\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.562\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00879\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2032\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-actin capping protein alpha-3 subunit (capz alpha-3) (germ cell- specific protein 3). [source:swissprot;acc:q96kx2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
215.322\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.46\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00872\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2033\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-actin capping protein beta subunit (capz beta). [source:swissprot;acc:p47756]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2034\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
centaurin beta 5 (cnt-b5). [source:swissprot;acc:q96p50]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.919\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.812\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00865\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2035\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
centaurin beta 2 (cnt-b2). [source:swissprot;acc:q15057]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2036\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lamin b1. [source:swissprot;acc:p20700]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
220.813\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2037\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
centaurin beta 1 (cnt-b1). [source:swissprot;acc:q15027]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
220.812\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2038\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lamin a/c (70 kda lamin). [source:swissprot;acc:p02545]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00864\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2039\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acetyl-coenzyme a synthetase, cytoplasmic (ec 6.2.1.1) (acetate--coa ligase) (acyl-activating enzyme) (acetyl-coa synthetase) (acs) (acecs). [source:swissprot;acc:q9nr19]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
190.551\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.191\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00861\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2040\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brachyury protein (t protein). [source:swissprot;acc:o15178]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.803\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00854\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2041\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin-1 ubiquitin-like interacting protein. [source:refseq;acc:nm\_020131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.808\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.141\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2042\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-box transcription factor tbx19 (t-box protein 19). [source:swissprot;acc:o60806]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.803\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2043\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquilin 1 isoform 1. [source:refseq;acc:nm\_013438]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.837\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.173\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2044\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 3 beta 1 subunit (beta-adaptin 3a) (ap-3 complex beta-3a subunit) (beta-3a-adaptin). [source:swissprot;acc:o00203]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
199.928\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
198.24\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00851\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2045\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ny-ren-24 antigen (fragment). [source:sptrembl;acc:q9y5a4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2046\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 3 beta 2 subunit (beta-adaptin 3b) (ap-3 complex beta-3b subunit) (beta-3b-adaptin) (neuron-specific vesicle coat protein beta-nap). [source:swissprot;acc:q13367]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2047\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [source:swissprot;acc:q9ugq3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
224.124\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.003\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00838\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2048\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [source:swissprot;acc:q9ny64]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2049\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b beta subunit (eif-2b gdp-gtp exchange factor) (s20i15) (s20iii15). [source:swissprot;acc:p49770]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.787\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.634\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00837\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2050\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh3 domain-binding glutamic acid-rich protein (sh3bgr protein) (21- glutamic acid-rich protein) (21-garp). [source:swissprot;acc:p55822]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.79\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.981\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00834\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2051\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oxidation resistance 1. [source:refseq;acc:nm\_181354]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2052\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase antizyme inhibitor. [source:swissprot;acc:o14977]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.667\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.95\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2053\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lats, large tumor suppressor, homolog 2; lats (large tumor suppressor, drosophila) homolog 2. [source:refseq;acc:nm\_014572]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.981\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2054\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase-like protein (ec 4.1.1.17) (odc-paralogue) (odc-p). [source:swissprot;acc:q96a70]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.665\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.948\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2055\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dymeclin. [source:refseq;acc:nm\_017653]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.79\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.981\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2056\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh3 domain-binding glutamic acid-rich-like protein. [source:swissprot;acc:o75368]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2057\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lats homolog 1. [source:refseq;acc:nm\_004690]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2058\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh3 domain-binding glutamic acid-rich-like protein 2 (fovea-associated sh3 domain binding protein). [source:swissprot;acc:q9ujc5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2059\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear receptor coactivator 7; estrogen receptor associated protein 140 kda. [source:refseq;acc:nm\_181782]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2060\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj132f21.2 (contains a novel protein similar to the l82e from drosophila) (fragment). [source:sptrembl;acc:q9h125]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2061\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tbc1 domain family protein c22orf4-like (fragment). [source:swissprot;acc:q9nu19]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2062\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tbc1 domain family protein c22orf4. [source:swissprot;acc:q8wua7]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2063\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase (ec 4.1.1.17) (odc). [source:swissprot;acc:p11926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.638\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.923\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00833\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2064\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aminoadipate-semialdehyde synthase; lysine-ketoglutarate reductase /saccharopine dehydrogenase; lysine-2-oxoglutarate reductase; aminoadipic semialdehyde synthase. [source:refseq;acc:nm\_005763]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.655\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.939\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2065\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 n (ec 6.3.2.19) (ubiquitin-protein ligase n) (ubiquitin carrier protein n) (ubc13) (bendless-like ubiquitin conjugating enzyme). [source:swissprot;acc:q16781]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.328\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.561\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00831\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2066\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proliferating cell nuclear antigen (pcna) (cyclin). [source:swissprot;acc:p12004]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.102\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00829\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2067\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate lyase (ec 4.3.2.2) (adenylosuccinase) (asl) (asase). [source:swissprot;acc:p30566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
193.226\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00828\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2068\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fas apoptotic inhibitory molecule. [source:refseq;acc:nm\_018147]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2069\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 1 (ec 2.7.1.-) (map kinase kinase 1) (mapkk 1) (erk activator kinase 1) (mapk/erk kinase 1) (mek1). [source:swissprot;acc:q02750]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.555\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.807\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0081\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2070\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rac gtpase activating protein 1; gtpase activating protein. [source:refseq;acc:nm\_013277]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.199\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.008\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2071\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to kinase suppressor of ras (fragment). [source:sptrembl;acc:q8ivt5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.555\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.807\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2072\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 2 (ec 2.7.1.-) (map kinase kinase 2) (mapkk 2) (erk activator kinase 2) (mapk/erk kinase 2) (mek2). [source:swissprot;acc:p36507]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2073\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
topoisomerase-related function protein 4-2. [source:refseq;acc:nm\_022447]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.267\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.433\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00806\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2074\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase gamma subunit 1 (ec 2.7.7.7) (mitochondrial dna polymerase catalytic subunit) (polg-alpha). [source:swissprot;acc:p54098]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.324\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.599\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00804\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2075\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cd109; gov system alloantigens on platelets. [source:refseq;acc:nm\_133493]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.703\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.483\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00803\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2076\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase nima-interacting 1 (ec 5.2.1.8) (rotamase pin1) (ppiase pin1). [source:swissprot;acc:q13526]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-4 (iroquois homeobox protein 4). [source:swissprot;acc:p78413]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fidgetin-like 1. [source:refseq;acc:nm\_022116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.511\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.814\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00794\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing gamma polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-gamma) (ptdins-3-kinase c2 gamma) (pi3k-c2gamma). [source:swissprot;acc:o75747]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.967\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00787\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/